info@mdrevenuegroup.com9:00 AM - 5:00 PM | Mon - Fri
MD Revenue Group provides specialized, high-performance revenue cycle management for independent infectious disease (ID) practices, multi-specialty head and neck groups, and specialized outpatient infusion and OPAT (Outpatient Parenteral Antibiotic Therapy) centers. We eliminate "Clinical Leakage" by mastering the complex 2026 shifts in prolonged E/M complexity (99417-99418), outpatient parenteral antibiotic therapy (OPAT) management, and the high-complexity documentation required for multi-system infection diagnostics. Our Medical Billing Services are engineered to transform your high-intensity ID practice from a cognitive-heavy task into a proactive capital recovery engine.
Claim Free Infectious Disease AuditFor an independent ID specialist, the choice to outsource RCM isn't about giving up control—it's about gaining technical leverage against aggressive payers who want to commoditize your high-acuity diagnostics. Our Medical Billing Services provide the administrative backbone required to allow your physicians and nurses to focus on patient outcomes rather than insurance friction.
As you add new physicians, specialized HIV counselors, or specialized TB/Wound mid-levels, your Revenue Cycle Management scales instantly without the need for additional Credentialing staff or office space.
By catching technical and mathematical errors (like Payer Enrollment gaps or unlinked hospital facility IDs) *before* submission, we dramatically accelerate your cash flow for high-volume hospital and office consultation cycles.
We build "Audit-Armor" into the foundation of your ID practice. Our experts ensure that every initial assessment, every infusion log, and every prolonged care record is "Ready for Scrutiny" before it ever leaves your office.
Infectious disease is a specialty defined by high cognitive intensity, multi-system clinical coordination, and the extreme administrative complexity of managing long-term outpatient infusions and biologic therapies. In 2026, the administrative friction between providers and payers has reached an all-time high, with payers using advanced AI-algorithms to audit "Time-Block Precision" and to challenge the "Medical Necessity" of same-day evaluation and diagnostic consults.
A primary source of revenue erosion for ID practices is the failure to properly document and bill for prolonged clinical time when dealing with multi-resistant or high-complexity infections. In 2026, if you provide 60 minutes of face-to-face physician time but fail to document the specific "Cumulative Time-Markers" required for the add-on codes, 100% of the additional revenue is lost. We implement Revenue Integrity protocols to ensure that every minute of clinical work is accurately remunerated.
Outpatient Parenteral Antibiotic Therapy (OPAT) is a high-value clinical stream that often suffers from uncaptured technical volume. In 2026, many practices lose 8-10% of their revenue simply by failing to reconcile the "Infusion-Hours" with the "Medication Units" (J-codes) for first-pass payment success. MDRG’s Revenue Cycle Management experts specialize in technical "Infusion-to-Billing" reconciliation.
In 2026, payers are using AI to automatically cross-reference ID consultations with specialized laboratory and pathology results. If the final diagnosis in the E/M claim doesn't perfectly correlate with the laboratory findings (e.g., culture results), the visit is auto-downcoded for "Lack of Clinical Support."
Topical authority in ID RCM involves mastering the high-complexity E/M 99000-series and the nuances of outpatient diagnostic antibiotic therapy. Our ID-certified coders ensure every Revenue Cycle Management submission is optimized for 2026 technical success.
MDM-based level selection parity
Exact minute-threshold documentation
Capturing J-code "Waste" units
Managing the "Consult-Request" bridge
Meeting the 60-min clinical threshold
2026 Medicare-specific time-blocks
Defending uncaptured biologic volume
In 2026, ID billing is a battle of "Cognitive Evidence." Payers are no longer just looking for coding errors; they are using AI-driven auditing to challenge the *time-intensity* and the *pathological synchronization* of your cases. We defend your revenue against these three high-frequency rejection types:
Payer bots often deny prolonged care add-ons (99417) if they detect a "Time-Sync Gap"—where the provider fails to document the exact start and stop times spent in face-to-face evaluation. In 2026, this is the #1 reason for diagnostic revenue erosion in ID.
For ID consults and infusion oversight, payers often trigger technical denials if the report doesn't explicitly link the *attending physician’s NPI* to the specific date of infusion. In 2026, if the "Oversight Note" lags more than 24 hours behind the "Infusion Date" without a clinical justification, the claim is auto-denied.
For newer specialized long-acting antiretroviral (ARV) injections or advanced HIV-prevention protocols, payers often trigger "Experimental" denials even for standard 2026 protocols.
In 2026, the key to infectious disease revenue is the "Cognitive Intensity Narrative." We help your providers implement "Audit-Armor" charting strategies that signal authority to payer algorithms. This includes using "Trigger Phrases" for visit necessity and automating the capture of specialized multi-system technical data.
We help you structure your consult summaries so that the "Technical Necessity" of a separately identifiable encounter is undeniable to even the most aggressive automated payer bots.
We teach your team how to describe complex resistant infections in a way that reflects the true "Sequential Intensity" of the Care, maximizing your per-session professional yield.
MDRG acts as your practice’s "Clinical-to-Financial Bridge." We focus entirely on Revenue Cycle Management efficiency so you can focus on clinical diagnostics and patient care.
We synchronize with your ID-specialized EHR (Athena, Mod-Med/EMA, eCW, NextGen, Greenway, etc.) to establish a clean, high-speed data bridge.
Every ID claim is scrubbed for 2026 CPT/Diagnosis parity before it hits the clearinghouse. We look for "Time-Threshold Red-Flags" that AI-payers use to auto-reject high-value prolonged care blocks.
We don't accept "No." We challenge every technical surgical and diagnostic denial with clinical precision, leveraging our certified coders to file high-level appeals for your most complex cases.
Track your net collections, "Per-Consult Technical Yield," and payer performance points with total transparency via our secure client portal.
To defend your cognitive revenue in 2026, your diagnostic and coordination records must be bulletproof. We provide our ID clients with a rigorous documentation checklist to ensure compliance:
In a technical audit for a 12-physician independent ID medical group in the Northeast, MDRG identified a $212,000 annual revenue leakage in their prolonged care (99417) and OPAT (Infusion-Hours) billing. The group was failing to correctly document "Time-Threshold Specificity" and was losing the technical value of their separately identifiable evaluation complexities during high-volume hospital weeks.
By implementing Revenue Cycle Management best practices—including real-time "Time-Capture Training" for their clinical staff—MDRG was able to: * **Recover $148,000 in uncaptured prolonged and infusion revenue** within the first 6 months. * **Reduce their "Time-Mismatch" Denial Rate** by 70% using specialized technical narratives. * **Accelerate Cash Flow** by reducing their average days in A/R from 48 days to 23 days.
This clinical group now operates with "Audit-Armor" protection, knowing that every high-volume patient diagnostic is protected from automated payer clawbacks.
In the high-intensity environment of 2026, your ID practice deserves a revenue cycle that is as precise as your clinical care. Don't let your "Cognitive Value" be eroded by primitive billing and administrative friction.
Direct PDF download. We respect medical practice privacy.
Get a free audit of your billing. If we don't find money you're leaving on the table, you don't pay a dime.
